Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Pro Farm Group, Inc. (MBII) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2022 8-K Quarterly results
07/11/2022 8-K Quarterly results
06/30/2022 8-K Quarterly results
05/19/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
03/28/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results"
03/16/2022 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "AGREEMENT AND PLAN OF MERGER",
"Schedule A",
"Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement"
02/22/2022 8-K Quarterly results
02/10/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/18/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Marrone Bio Innovations Issues Shareholder Letter"
01/06/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "FIRST AMENDMENT TO THE AMENDED INVENTORY FINANCING ADDENDUM",
"Marrone Bio’ s Inventory Line of Credit Increased to Support Sales and Manufacturing Growth"
11/10/2021 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Marrone Bio Innovations, Inc. Reports Third-Quarter 2021 Financial Results"
11/08/2021 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "Marrone Bio Innovations Receives Nasdaq Notice Regarding Failure to Satisfy a Continued Listing Rule"
08/30/2021 8-K Quarterly results
08/16/2021 8-K Quarterly results
05/28/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
04/28/2021 8-K Quarterly results
04/05/2021 8-K Quarterly results
03/23/2021 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2020 Financial Results",
"Letter to Shareholders"
02/25/2021 8-K Quarterly results
02/03/2021 8-K Quarterly results
01/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "1540 Drew Avenue ● Davis, CA 95618 ● Phone: 530-750-2800 MBI will provide you with a company cell phone and laptop computer. You will be eligible for the Company’ s benefits programs on the first day of the first full month of your employment. The benefits currently offered are as follows: ● Medical , Dental and Vision Insurance for you and your family. The Company will pay for 50% of your dependent premium for medical and dental insurance and you may pay the remaining 50% on a pre-tax basis under the Company’ s medical plan. ● Cafeteria Plan which gives you the ability to set aside a portion of your paycheck on a pre-tax basis for dependent premiums as well as set up a flexible spending account for dependent care and unreimbursed medical expenses. ● Long-term...",
"CHANGE IN CONTROL AGREEMENT This Change in Control Agreement is made and entered into by and between Suping Liu Cheung and Marrone Bio Innovations, Inc., a Delaware corporation , effective as of Executive’ s first date of employment by the Company . RECITALS 1. It is expected that the Company from time to time will consider the possibility of an acquisition by another company or other change in control. The Board of Directors of the Company recognizes that such consideration can be a distraction to Executive and can cause Executive to consider alternative employment opportunities. The Board has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of Executive, notwithstanding the possib...",
"Marrone Bio Appoints Sue Cheung New Chief Financial Officer"
01/05/2021 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "AMENDMENT TO THE VAN HERK WARRANT This Amendment to the Van Herk Warrant is entered into as of December 29, 2020 , by Marrone Bio Innovations, Inc., a Delaware corporation , Ospraie Ag Science LLC and Van Herk Investments B.V. . Reference is made to the Securities Purchase Agreement , dated December 15, 2017 by and among the Company and the investors referred to therein, and the warrant to purchase 5,333,333 shares of Common Stock issued pursuant to Section 1 of the SPA to Van Herk . Capitalized terms used herein and not otherwise defined shall have the definitions ascribed to such terms in the Van Herk Warrant."
11/09/2020 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Marrone Bio Innovations, Inc. Reports Third-Quarter 2020 Financial Results"
11/02/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors"
10/19/2020 8-K Quarterly results
09/23/2020 8-K Quarterly results
08/11/2020 8-K Quarterly results
08/10/2020 8-K Quarterly results
07/24/2020 8-K Quarterly results
07/06/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
Docs: "Marrone Bio Innovations, Inc. Reports First Quarter 2020 Financial Results"
05/05/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy